Group IIA secretory PLA2 inhibition by ursolic acid: A potent anti-inflammatory molecule

Current Topics in Medicinal Chemistry

Volumn 7, Issue 8, 2007, Pages 801-809

  Nataraju, A ^a   Raghavendra Gowda, C D ^a   Rajesh, R ^a   Vishwanath, B S ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Dialysis; Edema; Enzyme ursolic acid complex; Fluorescence spectroscopy; Hemolytic activity

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCIUM; PHOSPHOLIPASE A2 INHIBITOR; SNAKE VENOM; URSOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSIS; ENZYME INHIBITION; ENZYME PURIFICATION; FLUORESCENCE ANALYSIS; HEMOLYSIS; HUMAN; IC 50; IN VIVO STUDY; MOUSE; NONHUMAN; PAW EDEMA; PLEURA FLUID; REVIEW; SNAKE; SYNOVIAL FLUID;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIUM; EDEMA; ENZYME INHIBITORS; HEMOLYSIS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; PHOSPHOLIPASES A; PLEURAL CAVITY; SNAKE VENOMS; SPECTRUM ANALYSIS; SYNOVIAL FLUID; TRITERPENES;

EID: 34247620325     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802607780487696     Document Type: Review

References (44)

1. 2 in development. Curr. Pharm. Des. 2001, 7, 181-198.
2. 2 Group IIA. Curr. Med. Chem. 2005, 12, 3011-3026.
3. Asero, R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J. Allergy Clin. Immunol. 2003, 111(5), 1095-1098.
4. Erbagci, Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J. Dermatol. 2004, 31(5), 376-382.
5. 2 (s); comparison of arachidonoyl-selective and non-selective enzymes. FASEB J. 1993, 7, 339-348.
6. 2. Biol. Pharm. Bull. 2004, 27(8), 1158-1164.
7. Liu, J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995, 49(2), 57-68.
8. Liu, J. Oleanolic acid and ursolic acid: Research perspectives. J Ethnopharmacol. 2005, 100(1-2), 92-94.
9. Balanehru, S.; Nagarajan, B. Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int. 1991, 24(5), 981-990.
10. 2 from synovial fluid in rheumatoid arthritis. J. Biochem. 1986, 100(5), 1297-1303.
11. 2 from Russell's viper (Vipera russelli venom. Toxicon 1989, 27(2), 229-237.
12. 2 from Indian cobra (Naja naja naja) venom. Toxicon 1988, 36(6), 921-932.
13. Lowry, O.H.: Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193(1), 265-275.
14. Patriarca, P.; Beckerdite, S.; Elsbach, P. Phospholipases and phospholipid turnover in Escherichia coli spheroplasts. Biochim. Biophys. Acta 1972, 260(4), 593-600.
15. 2 activity in rats. J. Clin. Invest. 1993, 92(4), 1974-1980.
16. www.embl-heidelberg.de/~andrade/k2dfaq.htmal.
17. Boman, H.G.; Kaletta, U. Chromatography of rattlesnake venom; a separation of three phosphodiesterases. Biochim. Biophys. Acta 1957, 24(3), 619-631.
18. Yamakawa, M.M.; Hokama, N.Z. Fractionation of Sakishima habu (T. elegans) venom and lethal hemorrhagic and edema forming activity of the fractions. In: A. Ohsaka, K. Hayashi and Y. Sawai (ed). Animal plant and microbial toxins. Plenum press, New York, 1976, Vol 1, p.97.
19. 2 enzymes from habu (Trimeresurus flavovoridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 1987, 25, 501-515.
20. 2 in inflammation. Adv. Inflam. Res. 1984, 7, 51-59.
21. 2 as multivalent mediators of inflammatory and allergic disorders. Int. Arch. Allergy Immunol. 2003, 131(3), 153-63.
22. Six, D.A.; Dennis, E.A. The expanding superfamily of phospholipase A(2) enzymes: Classification and characterization. Biochim. Biophys. Acta 2000, 1488(1-2), 1-19.
23. Chakraborti, S. Phospholipase A(2) isoforms: A perspective. Cell. Signal. 2003, 15(7), 637-665.
24. 2 from Vipera russelli (Russell's viper) snake venom. Toxicon 1988, 26(8), 713-720.
25. 2-induced pleural inflammation in rats. Int. J. Tissue React. 1989, 11(3), 129-136.
26. 2 in rheumatoid arthritis. Adv. Exp. Med. Biol. 1990, 279, 231-238.
27. 2. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 175-189.
28. Deepa, M.; Veerabasappa Gowda, T. Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch. Biochem. Biophys. 2002, 408(1), 42-50.
29. 2 in development. Curr. Pharm. Des. 2001, 7, 181-198.
30. Kim, H.P.; Son, K.H.; Chang, H.W.; Kang, S.S. Anti-inflammatory plant flavonoids and cellular action mechanism. J. Pharmacol. Sci. 2004, 96, 229-245.
31. 2 Group IIA. Curr. Med. Chem. 2005, 12, 3011-3026.
32. 2) activity by nifedipine and nisoldipme is independent of their calcium-channel-blocking activity. Inflammation 1987, 11 3), 353-364.
33. 2 by minocycline and doxycycline. Biochem. Pharmacol. 1992, 4 6), 1115-1170.
34. 2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J. Biol. Chem. 1987, 262(4), 1698-1705.
35. 2 by retinoids and flavonoids: Mechanism of action. Agents Actions 1988, 25(3-4), 394-400.
36. Venyaminov, S.Y.; Yang, J.T. Determination of protein secondary structure. In: G. D. Fasman (ed). Circular dichroism and the conformational analysis of biomolecules, Plenum Press, Ney York, 1996 pp. 69.
37. 2 from Vipera russelli venom with aristolochic acid: A circular dichroism study. Toxicon 1987, 25(9), 939-946.
38. Lin, Y.H.; Huang, W.N.; Lee, S.C.; Wu, W.G. Heparin reduces the alpha-helical content of cobra basic phospholipase A(2) and promotes its complex formation. Int. J. Biol. Macromol. 2000, 27 2), 171-176.
39. 2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages. Inflammation 1990, 14 5), 543-559.
40. 2 and inflammation responses in mice. Life Sci. 1994, 54, 333-338.
41. 2 inhibitors. Fed. Proc. 1987, 46, 854-862.
42. 2 enzymes. Biochem. J. 1996, 15, 320, 93-99.
43. 2 with anti-inflammatory activity. Int. J. Mol. Med. 2005, 16 5), 895-904.
44. Jameel, N.M.; Frey, B.M.; Frey, F.J.; Gowda, T.V.; Vishwanath, B.S. Inhibition of secretory phospholipase A(2) enzyme by bilirubin: A new role as endogenous anti-inflammatory molecule. Mol. Cell. Biochem. 2005, 276(1-2), 219-225.